ETON vs PCRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 05, 2026
ETON
56.6
AI Score
VS
It's a Tie!
PCRX
56.6
AI Score
Investment Advisor Scores
PCRX
57score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | ETON | PCRX | Winner |
|---|---|---|---|
| Revenue | 24.27M | 177.38M | PCRX |
| Net Income | 1.55M | 2.92M | PCRX |
| Net Margin | 6.4% | 1.6% | ETON |
| Operating Income | 2.41M | 6.90M | PCRX |
| ROE | 5.1% | 0.4% | ETON |
| ROA | 1.6% | 0.2% | ETON |
| Total Assets | 97.71M | 1.21B | PCRX |
| Cash | 19.66M | 144.31M | PCRX |
| Debt/Equity | 0.62 | 0.56 | PCRX |
| Current Ratio | 1.21 | 4.73 | PCRX |
| Free Cash Flow | 7.33M | 22.96M | PCRX |
Frequently Asked Questions
Based on our detailed analysis, ETON and PCRX are evenly matched, both winning 3 key financial metrics each. This is a close call that depends on your specific investment goals.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.